CA
IDXX icon

Commerzbank Aktiengesellschaft’s Idexx Laboratories IDXX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
647
-230
-26% -$129K 0.01% 290
2026
Q1 		$493K Sell
877
-41
-4% -$26.3K 0.01% 262
2025
Q4 		$621K Hold
918
– – 0.01% 262
2025
Q3 		$587K Hold
918
– – 0.01% 248
2025
Q2 		$493K Hold
918
– – 0.01% 245
2025
Q1 		$386K Hold
918
– – 0.01% 260
2024
Q4 		$379K Buy
918
+262
+40% +$115K 0.01% 249
2024
Q3 		$332K Buy
656
+134
+26% +$65.1K 0.01% 231
2024
Q2 		$255K Sell
522
-96
-16% -$48.2K 0.01% 214
2024
Q1 		$334K Buy
618
+100
+19% +$54.6K 0.01% 191
2023
Q4 		$288K Buy
+518
New +$243K 0.01% 164
2020
Q1 		– Sell
-5,877
Closed -$1.53M – 580
2019
Q4 		$1.53M Sell
5,877
-437
-7% -$115K 0.01% 381
2019
Q3 		$1.72M Buy
6,314
+4,242
+205% +$1.18M 0.01% 443
2019
Q2 		$570K Buy
+2,072
New +$511K ﹤0.01% 719
2019
Q1 		– Sell
-1,489
Closed -$277K – 935
2018
Q4 		$277K Sell
1,489
-16,395
-92% -$3.36M ﹤0.01% 776
2018
Q3 		$4.46M Buy
17,884
+15,622
+691% +$3.79M 0.04% 306
2018
Q2 		$493K Sell
2,262
-3,577
-61% -$737K ﹤0.01% 669
2018
Q1 		$1.12M Sell
5,839
-1,159
-17% -$214K 0.01% 512
2017
Q4 		$1.09M Buy
6,998
+3,093
+79% +$487K 0.01% 512
2017
Q3 		$607K Buy
+3,905
New +$617K 0.01% 564
2017
Q2 		– Sell
-4,149
Closed -$641K – 795
2017
Q1 		$641K Sell
4,149
-1,549
-27% -$214K 0.01% 577
2016
Q4 		$668K Buy
5,698
+1,791
+46% +$204K 0.01% 526
2016
Q3 		$440K Sell
3,907
-1,123
-22% -$118K 0.01% 603
2016
Q2 		$467 Buy
+5,030
New +$432K ﹤0.01% 694
2014
Q1 		– Sell
-10,292
Closed -$588K – 1286
2013
Q4 		$588K Buy
10,292
+498
+5% +$26.2K ﹤0.01% 1012
2013
Q3 		$488K Sell
9,794
-138
-1% -$6.63K ﹤0.01% 989
2013
Q2 		$445K Buy
+9,932
New +$434K ﹤0.01% 1101

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Commerzbank Aktiengesellschaft's IDXX Position: Q2 2026 in Review

Commerzbank Aktiengesellschaft reduced its Idexx Laboratories (IDXX) stake by 26% in Q2 2026, selling an estimated $129K and leaving 647 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #290.

Commerzbank Aktiengesellschaft first reported a position in IDXX in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.46M in Q3 2018. 776 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Commerzbank Aktiengesellschaft held 647 shares of Idexx Laboratories worth $341K as of Q2 2026.
  • Commerzbank Aktiengesellschaft sold 230 Idexx Laboratories shares in Q2 2026, an estimated $129K.
  • Idexx Laboratories made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #290 holding.
  • Commerzbank Aktiengesellschaft first reported a position in Idexx Laboratories in Q2 2013 and has held it in 27 quarters since.
  • Commerzbank Aktiengesellschaft's Idexx Laboratories position peaked at $4.46M in Q3 2018.
  • 776 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.